scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in scPharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +2 vs. Q2 2022
- Shares held
- 14.0M
- −1.67M (−10.7%) vs. Q2 2022
- Total value
- $91.3M
- +$15.4M (+20.2%) vs. Q2 2022
- New holders
- 4
- 9 more added
- Sold out
- 2
- 15 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 12 | $0 | 0.00% | −2,044−99.4% | Reduced |
| Wells Fargo & Company | 64 | $0 | 0.00% | −2−3.0% | Reduced |
| BNP Paribas Arbitrage, SA | 106 | $691 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 715 | $5.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,926 | $32.0K | 0.00% | +2,263+85.0% | Added |
| Tower Research Capital LLC (TRC) | 8,016 | $52.0K | 0.00% | +1,520+23.4% | Added |
| Sandy Cove Advisors, LLC | 10,592 | $69.0K | 0.06% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 11,573 | $75.0K | 0.00% | +11,573 | New |
| Envestnet Asset Management Inc | 14,186 | $92.0K | 0.00% | +14,186 | New |
| IPG Investment Advisors LLC | 14,300 | $93.2K | 0.03% | 00.0% | Unchanged |
| Ritholtz Wealth Management | 15,000 | $98.0K | 0.01% | +15,000 | New |
| Commonwealth Equity Services, LLC | 15,530 | $101.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 17,360 | $113.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 21,219 | $138.0K | 0.01% | −38,696−64.6% | Reduced |
| Wolverine Trading, LLC | 23,282 | $141.0K | 0.01% | +9,512+69.1% | Added |
| Millennium Management LLC | 25,317 | $165.0K | 0.00% | −10,899−30.1% | Reduced |
| Group One Trading, L.P. | 27,060 | $176.0K | 0.01% | +25,738+1,946.9% | Added |
| Thomasville National Bank | 27,500 | $179.0K | 0.02% | +12,500+83.3% | Added |
| Citadel Advisors LLC | 27,936 | $182.0K | 0.00% | −19,298−40.9% | Reduced |
| Bank of New York Mellon Corp | 34,206 | $223.0K | 0.00% | 00.0% | Unchanged |
| Zacks Investment Management | 36,989 | $241.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 40,751 | $266.0K | 0.01% | −44,711−52.3% | Reduced |
| Northern Trust Corp | 49,583 | $323.0K | 0.00% | +1,477+3.1% | Added |
| J. Goldman & Co LP | 50,625 | $330.0K | 0.02% | +50,625 | New |
| Susquehanna International Group, LLP | 63,158 | $412.0K | 0.00% | −9,465−13.0% | Reduced |
| BlackRock Inc. | 64,802 | $422.0K | 0.00% | +140.0% | Added |
| Geode Capital Management, LLC | 85,185 | $555.0K | 0.00% | +6,611+8.4% | Added |
| Morgan Stanley | 93,289 | $608.0K | 0.00% | −2,414−2.5% | Reduced |
| Belvedere Trading LLC | 120,706 | $661.0K | 0.73% | −118,513−49.5% | Reduced |
| Bridgeway Capital Management, LLC | 132,200 | $862.0K | 0.02% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 139,119 | $906.0K | 0.00% | +22,677+19.5% | Added |
| Renaissance Technologies LLC | 180,286 | $1.18M | 0.00% | −11,300−5.9% | Reduced |
| Worth Venture Partners, LLC | 188,522 | $1.23M | 0.77% | −147,463−43.9% | Reduced |
| Ikarian Capital, LLC | 479,383 | $3.13M | 1.56% | −404,625−45.8% | Reduced |
| Vanguard Group Inc | 616,558 | $4.02M | 0.00% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 757,063 | $4.94M | 1.94% | −589,661−43.8% | Reduced |
| Armistice Capital, LLC | 2,492,000 | $16.2M | 0.41% | −208,000−7.7% | Reduced |
| 5AM Venture Management, LLC | 3,334,852 | $21.7M | 4.17% | −226,622−6.4% | Reduced |
| OrbiMed Advisors LLC | 4,797,148 | $31.3M | 0.62% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,999−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,152−100.0% | Sold out |